Alantos Pharmaceuticals
Latest round
- Series B
Last raised
- Mar 2005
Total raised
- $20M
Investors
- 6
About Alantos Pharmaceuticals
Founded in 1999, Alantos Pharmaceuticals is a bio-pharmaceutical company, which develops small molecule drugs for type 2 diabetes and osteoarthritis/inflammation based diseases.
Who invested in Alantos Pharmaceuticals
6 investors across 1 round
See all investors in Alantos Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 10, 2005
Amount
$20M
Investors
Questions about Alantos Pharmaceuticals
Who invested in Alantos Pharmaceuticals?
Alantos Pharmaceuticals has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alantos Pharmaceuticals raised?
Alantos Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Alantos Pharmaceuticals last raise money?
Alantos Pharmaceuticals's most recent round on record is a Series B, in Mar 2005.
What does Alantos Pharmaceuticals do?
Founded in 1999, Alantos Pharmaceuticals is a bio-pharmaceutical company, which develops small molecule drugs for type 2 diabetes and osteoarthritis/inflammation based diseases.
Where is Alantos Pharmaceuticals headquartered?
Alantos Pharmaceuticals is headquartered in Heidelberg, Germany.
Which VCs invest in companies like Alantos Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Alantos Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Alantos Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.